首页> 外国专利> ALLEVIATION AND TREATMENT OF ISCHEMIA REPERFUSION-INDUCED LUNG INJURY USING PLURIPOTENT STEM CELLS

ALLEVIATION AND TREATMENT OF ISCHEMIA REPERFUSION-INDUCED LUNG INJURY USING PLURIPOTENT STEM CELLS

机译:多能干细胞对缺血再灌注诱导的肺损伤的缓解和治疗

摘要

The purpose of the present invention is to provide a novel medical use of pluripotent stem cells (Muse cells) in regenerative medicine. The present invention provides a cell preparation and a pharmaceutical composition which contain SSEA-3 positive pluripotent stem cells isolated from mesenchymal tissue of a living organism or cultured mesenchymal cells, and which are intended for alleviation and treatment of ischemia reperfusion-induced lung injury. The cell preparation according to the present invention is based on a mechanism in which Muse cells are administered to a subject having the abovementioned disease to engraft the cells into lung tissues, and the disease is alleviated and treated.
机译:本发明的目的是提供多能干细胞(Muse细胞)在再生医学中的新医学用途。本发明提供了一种细胞制剂和药物组合物,其包含从活生物体的间充质组织或培养的间充质细胞中分离的SSEA-3阳性多能干细胞,旨在减轻和治疗缺血再灌注诱导的肺损伤。根据本发明的细胞制剂基于这样的机制,其中将Muse细胞给予患有上述疾病的受试者以将细胞移植到肺组织中,并且该疾病得以缓解和治疗。

著录项

  • 公开/公告号US2019201456A1

    专利类型

  • 公开/公告日2019-07-04

    原文格式PDF

  • 申请/专利权人 LIFE SCIENCE INSTITUTE INC.;

    申请/专利号US201716322725

  • 申请日2017-08-03

  • 分类号A61K35/545;A61P11;A61L27/38;C12N5/0775;

  • 国家 US

  • 入库时间 2022-08-21 12:07:05

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号